News & Updates
Filter by Specialty:
Patients at risk for BE worried over EAC but rarely undergoes screening: study
Patients who are prone to Barrett’s esophagus (BE), specifically those belonging to racial and ethnic minorities, express concern about developing esophageal adenocarcinoma (EAC), reveals a study. However, they seldom go through screening and lack awareness of screening recommendations.
Patients at risk for BE worried over EAC but rarely undergoes screening: study
25 Apr 2023Psilocybin shows therapeutic potential for depression
For cancer patients with depression, treatment with a single dose of psilocybin appears to yield rapid and meaningful improvements in depressive symptoms, as shown in a phase II study.
Psilocybin shows therapeutic potential for depression
24 Apr 2023Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
Mirvetuximab soravtansine (MIRV), an antibody drug conjugate (ADC), showed antitumour activity in women with platinum-resistant ovarian cancer* (PROC) with high folate receptor alpha (FRα) expression, findings from the phase III SORAYA study have shown.
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
20 Apr 2023Maximal transurethral resection tied to better outcomes at cystectomy
Pathological response at cystectomy may improve with maximal resection in patients undergoing transurethral resection for muscle-invasive bladder cancer prior to neoadjuvant chemotherapy, according to a study.